Precigen Terminates License Agreement With Alaunos Therapeutics
Alaunos Therapeutics Ends Licensing Deal, Reassesses Strategy
Express News | Alaunos Therapeutics : Co Provided Written Notice to Precigen to Terminate a&R License Agreement
Alaunos Therapeutics | 10-Q: Q2 2024 Earnings Report
Why Domino's Pizza Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Express News | Alaunos Therapeutics Shares Are Trading Lower After the Company Announced a 1-for-10 Reverse Stock Split
Express News | Tuesday, Alaunos Therapeutics Announced A Reversed Stock Split Of 1-for-10, Effective July 18-8K
Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Express News | Alaunos Therapeutics: Filed 3Rd Amended & Restated Certificate of Incorporation to Effect Reverse Stock Split of Common Stock at Ratio of 1-for-10
12 Health Care Stocks Moving In Thursday's Intraday Session
BioSig Technologies Appoints Ferdinand Groenewald as Interim CFO
Alaunos Therapeutics | 10-Q: Q1 2024 Earnings Report
Alaunos Therapeutics Announces Executive Financial Leadership Changes
Alaunos Therapeutics Regains Nasdaq Listing Compliance
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
TCRT, NXT and MINM Among Mid-day Movers
Express News | Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Alaunos Therapeutics To Carry Out 1-for-15 Reverse Stock Split On February 1st, 2024
Express News | Alaunos Therapeutics Appoints Dale Curtis Hogue As Interim CEO, Effective Jan. 20 2024; Hogue Will Continue Serving On The Board
12 Health Care Stocks Moving In Friday's Pre-Market Session